CIDRZ
Lusaka, Lusaka Province, 10101, Zambia
NCT Number: NCT07749872
The study was designed as a descriptive cross-sectional survey conducted between February and October 2022. Senior management officials were targeted because of their role in workplace policy and oversight. The sample was drawn from companies registered under the Zambia Chamber of Commerce and Industry (ZACCI), focusing on those with known silica dust exposure. Each company was asked to provide one or two senior officials to participate. A total of 118 individuals completed the survey.
Data collection was carried out using a self-administered electronic questionnaire developed in line with WHO recommendations for TB KAP surveys. The questionnaire contained 28 mandatory closed-ended questions: 7 on knowledge, 8 on attitudes, and 13 on practices (with 5 practice questions excluded from scoring as they were programmatic). Responses were validated by three medical doctors, and scoring was based on correct answers. Knowledge, attitude, and practice scores were categorized into "poor" or "good" using mean or median cutoffs depending on distribution. Logistic regression was applied to explore associations between participant characteristics and KAP outcomes.
Looking for future studies?
Notify MeAll sexes
Observational
Lusaka, Lusaka Province, 10101, Zambia
Tuberculosis (TB) continues to pose a significant global health burden, particularly among individuals in the economically productive age group of 15-64 years. In Zambia, 85% of TB cases occur in this demographic, underscoring the dual public health and socio-economic impact. The risk is compounded in industries with high exposure to crystalline silica dust, such as mining, construction, drilling, cement, brick, tile, glass, and ceramics manufacturing. Prolonged inhalation of silica dust can lead to silicosis, a condition that increases the risk of TB three to four times compared to individuals without silicosis. Even without silicosis, silica exposure alone elevates TB risk. Poor workplace conditions, including overcrowding and inadequate ventilation, further exacerbate transmission risks.
Recognizing these occupational hazards, the study aimed to assess the knowledge, attitudes, and practices (KAP) of senior management officials in companies with high silica exposure. These officials play a critical role in shaping workplace policies and interventions, making their understanding and attitudes toward TB prevention and management essential for effective workplace health strategies.
The research was conducted as a descriptive cross-sectional study between February and October 2022 in Lusaka and Southern provinces of Zambia. These provinces were selected due to their concentration of industries associated with silica dust exposure. The study focused on senior management officials, defined as either the most senior staff in an organization or heads of divisions/departments, given their influence on workplace health policies.
The sample population was drawn from the Zambia Chamber of Commerce and Industry (ZACCI), an umbrella organization representing businesses across all sectors. ZACCI advocates for workplace legislation and a conducive business environment. Companies known to produce silica dust were identified under categories including mining, construction, cement manufacturing, brick and tile manufacturing, and glass and ceramic manufacturing. The sampling frame included 1 mining company, 73 construction companies, 1 cement company, 9 brick/tile companies, and 10 glass/ceramic companies.
Each company was asked to nominate at least one senior official to complete the questionnaire, with a maximum of two responses per company. This ensured representation across industries while maintaining focus on individuals with policy-making authority.
Data were collected using a multiple-choice electronic questionnaire developed in accordance with WHO guidelines for TB KAP surveys. The questionnaire was self-administered in English via Google Forms and contained 28 mandatory closed-ended questions:
Responses were validated by three medical doctors. A response was considered correct if at least two doctors agreed. This ensured accuracy and minimized bias in scoring. Responses marked as "don't know," "not sure," or "other" were treated neutrally with a score of 0. Ambiguous "other" responses were excluded from analysis.
Survey responses were stored on Google Forms, downloaded into a CSV file, and imported into Python (version 3.8) for recoding. The dataset was then analyzed using STATA (version 18.5). Descriptive statistics were used to summarize participant characteristics and categorical variables.
A scoring system was applied:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Conducted between February 2022 to October 2022
Descriptive Cross - sectional study
Centre for Infectious Disease Research in Zambia
Other
Knowledge, Attitude, and Practices Regarding TB Among Senior Management Officials of Companies With Increased Silica Dust Exposure in Lusaka and Southern Provinces of Zambia
Acronym: KAP TB
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06314386
Actinomycetales Infections, Bacterial Infections
Addo, South Africa
View Trial DetailsNCT03187964
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Cape Town, Western Cape, South Africa
View Trial DetailsNCT07227779
Actinomycetales Infections, Bacterial Infections
Kampala, Uganda
View Trial DetailsNCT07706972
Actinomycetales Infections, Bacterial Infections
View Trial Details